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A measles outbreak occurred from November 2015 
to April 2016 in two northern Italian regions, affect-
ing the Roma/Sinti ethnic population and nosocomial 
setting. Overall, 67 cases were reported. Median 
age of 43 cases in three Roma/Sinti camps was four 
years, nosocomial cases were mainly adults. The out-
break was caused by a new measles virus B3.1 vari-
ant. Immunisation resources and strategies should be 
directed at groups with gaps in vaccine coverage, e.g. 
Roma/Sinti and healthcare workers. 
Despite a national goal to eliminate measles by 2015, 
Italy is one of 18 European Region Member States 
where endemic transmission of measles has not been 
interrupted [1]. We report here a recent measles out-
break in northern Italy (Figure 1) affecting the Roma/
Sinti ethnic population and the nosocomial setting.
Outbreak description
Measles cases were reported to the Italian national 
integrated measles and rubella surveillance system 
coordinated by the Istituto Superiore di Sanità in Rome.
Milan clusters (Lombardy region, northern 
Italy)
The outbreak originated in a nomadic settlement in 
Milan and then spread to two other settlements in the 
city. The three settlements house persons of mainly 
Roma/Sinti ethnic origin but also migrants of vari-
ous nationalities. A large degree of social interaction 
occurs between the three camps, as they are inhabited 
by related family groups.
In total, 43 cases were reported with dates of rash 
onset from 7 November 2015 to 18 February 2016 
(weeks 45/2015 to 7/2016). Figure 2 shows the number 
of reported measles cases by date of symptom onset. 
Forty of 43 cases were Roma/Sinti while three were 
migrants, including one individual from North Africa 
and two from South Asia. Median age of the 43 cases 
was four years (range: 5 months–29 years) and 39 
were 15 years or younger. Thirty-nine of 43 cases were 
unvaccinated. Of the four vaccinated cases, three had 
received post-exposure vaccination in connection with 
the outbreak. 
Twenty-seven cases were laboratory-confirmed and 16 
were probable cases [2]. Twelve cases reported compli-
cations, including six cases of pneumonia, four cases 
of diarrhoea and two cases of otitis media. Eighteen 
cases were admitted to hospital and 14 were seen in 
the emergency department but not admitted.
Parma and Piacenza clusters (Emilia Romagna 
region, northern Italy)
The outbreak spread from Lombardy to Emilia Romagna 
in the cities of Parma (17 cases from 13 January to 13 
April) and Piacenza (seven cases from 6 March to 3 
April 2016). Here, transmission occurred mainly in the 
nosocomial setting.
The Parma cluster originated from an unvaccinated 
adult, employed near a Roma camp in Milan, who was 
visiting Parma. While there, the patient developed 
fever in early January 2016 and was hospitalised four 
days later. Measles was diagnosed after two more 
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days, following rash onset. While hospitalised, the 
case transmitted the infection to an unvaccinated adult 
sibling. Two healthcare workers (HCW) in the same hos-
pital and two persons who visited the hospital during 
the outbreak period also developed measles, although 
no direct contact with any of the other identified cases 
was reported. One of the HCW transmitted the infec-
tion to another HCW. Other cases related to this cluster 
included four HCW working in different healthcare set-
tings in the community and six persons with no appar-
ent contact with any of the above cases. All 17 cases 
were linked virologically. Median age was 37 years 
(range: 22–49 years). None were vaccinated. One case 
was complicated by keratoconjunctivitis.
The Piacenza cluster originated from a hospital worker 
with no direct patient contact, who was hospitalised 
with high fever over 14 days starting in the first week 
of March, but in whom a diagnosis of measles was 
made only retrospectively, after hospital discharge, 
when four unvaccinated HCW in the same hospital 
developed measles. Two HCW transmitted the infec-
tion to a relative outside the hospital setting. Median 
age of these seven cases was 40 years (range: 35–68 
years). A high rate of complications occurred among 
cases: three developed pneumonia, two of them with 
acute respiratory insufficiency, three developed diar-
rhoea, two keratoconjunctivitis, one pericarditis, one 
thrombocytopenia and one Guillain-Barré syndrome. In 
addition, five of seven cases developed increased liver 
enzymes. All HCW were admitted to hospital.
Genotyping and phylogenetic analysis
We performed a genetic analysis of measles viruses 
isolated from 14 of 43 cases from the three Roma 
camps (respectively, two, 11 and one strain from camps 
1, 2 and 3) and 22 of 24 cases from the clusters in 
Emilia Romagna (respectively, 17 and five cases from 
the Parma and Piacenza clusters). Phylogenetic analy-
sis based on the available partial nucleoprotein gene 
sequences showed that all sequences were identical to 
each other and belonged to genotype B3.1 (Figure 3) 
[3,4]. 
BLAST analysis of the World Health Organization’s 
measles nucleotide surveillance (MeaNS) database 
[5,6] shows that the strain identified represented a 
new variant of this genotype, first reported in August 
2015 (week 32/2015) in Como (Lombardy) and Rimini 
(Emilia-Romagna), in two cases for whom no epidemio-
logical link was found.
Since August 2015 and up to April 2016, besides the 
outbreak cases, the new B3 variant has also been 
identified in other cases with no epidemiological link 
to the outbreak. In total, it has been identified in 17 
non-Roma cases in various cities in Lombardy and four 
cases in Emilia-Romagna in cities other than Parma 
and Piacenza (Figure 3). 
All sequences are available in the MeaNS database 
(sequence ID numbers: 86275-86278, 86280-86281, 
86283, 86285-86323, 89315-89325) [5,6]. 
Outside of Italy, identical sequences have been iden-
tified in Spain, Germany, and the United Kingdom in 
August to September 2015 (before the described out-
break, weeks 35–39/2015) and in Romania in January 
2016 (week 3/2016).
Control measures
Staff of the local health authorities in Milan visited the 
three settlements on several occasions, together with 
cultural mediators, to identify contacts and search for 
additional cases. All persons 18 years or younger were 
invited to the vaccination centre for post-exposure 
prophylaxis. At the time of the visits, 54, 165 and 27 
persons, respectively, were present in the three camps, 
of whom 52 (38 aged ≤ 18 years) received vaccination.
In Emilia Romagna, contacts were invited to be vac-
cinated. Overall 17 contacts were vaccinated (15 were 
older than 18 years).
In both regions, local health authorities informed local 
hospitals, emergency departments, family physicians/
paediatricians and the local media of the outbreaks, 
and urged physicians to investigate all suspected mea-
sles cases, to isolate them if infectious and to notify 
Figure 1
Areas involved in a measles outbreak affecting the Roma/
Sinti population with transmission in the nosocomial 
setting, Italy, November 2015–April 2016
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cases immediately. In Emilia Romagna, occupational 
physicians were reminded to implement the regional 
recommendation to verify measles immunity status 
of all unvaccinated hospital staff and staff of commu-
nity healthcare services, and to offer vaccination to all 
those found to be susceptible. Results on uptake are 
pending at the time of publication. 
Discussion
This outbreak highlights the immunity gaps existing in 
Roma/Sinti population groups and HCW in Italy. Both 
are considered to be hard-to-reach populations and 
outbreaks have also been reported in Europe and other 
industrialised countries [7-9].
The Roma people are a heterogeneous nomadic eth-
nic group who live in many countries worldwide but 
primarily in Europe. An estimated 140,000 Roma live 
in Italy (ca 3,400 in Milan). It is difficult to monitor 
uptake of measles-mumps-rubella vaccine among the 
Roma, but it is known to be low [9]. In this outbreak, a 
high level of susceptibility was found among children 
(median age of cases: 4 years), confirming a low vacci-
nation uptake. Barriers to vaccination among the Roma 
have been previously described [9].
In Milan, the outbreak in the Roma settlement did not 
spread extensively in the community and no nosoco-
mial cases were reported, despite the high number 
of cases that sought medical treatment. On the other 
hand, in Emilia Romagna, transmission occurred 
mainly in the nosocomial setting, suggesting that vac-
cination coverage is low among HCW in this region. In 
both regions, measles vaccination uptake in 2015 was 
above the national average but below the target of 95% 
for both doses (first-dose coverage in two-year old chil-
dren 89.5% and 88.3%,respectively, in Lombardy and 
Emilia Romagna; second-dose coverage in six year-old 
children 91% in both regions) [10].
Despite a thorough investigation, no source of expo-
sure was found for some cases in Parma and Piacenza 
and phylogenetic analysis was essential to confirm 
connections among cases. It is likely that not all cases 
were detected by the surveillance system, the sensitiv-
ity of which should be strengthened by raising aware-
ness of measles among physicians and increasing the 
rate of suspected cases being tested. However, it is 
known that many measles cases do not seek health 
care and this may also have affected sensitivity. Some 
cases were initially misdiagnosed, probably because 
many clinicians are no longer familiar with the clinical 
presentation of measles. They need to be reminded to 
consider measles in the differential diagnosis of any 
febrile rash illness, especially in unvaccinated per-
sons, and to immediately report suspected case to 
public health authorities so that control measures can 
be implemented rapidly.
Three cases were detected among migrants living 
in one of the Roma settlements in Milan. It is possi-
ble that other undetected measles cases may have 
occurred among migrants living temporarily in the 
settlement. However, this is unlikely, as local health 
authorities, together with cultural mediators, visited 
the camp repeatedly during the outbreak and did not 
detect other cases. At the time of the outbreak, only 
a very small minority of persons living in one of the 
camps were migrants. These were persons of southern 
Asian and northern African origin who have access to 
medical care and immunisations in Italy. 
MeaNS data from the last 12 months show that mea-
sles virus genotype B3 was endemic in several coun-
tries worldwide [6]. The appearance of a new B3 variant 
in Italy is probably due to importation, however, the 
route of introduction remains unknown.
To achieve measles elimination, besides strengthen-
ing surveillance and improving vaccination coverage 
in the general population, immunisation resources and 
Figure 2
Number of reported measles cases by date of symptom onset, outbreak involving the Roma/Sinti population in Milan and 
spreading to Parma and Piacenza, Italy, November 2015–April 2016 (n = 67)
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Figure 3
Neighbour-joining tree for nucleotide sequences of a new measles virus B3.1 variant causing an outbreak involving the 
Roma/Sinti population and the nosocomial setting, Italy, November 2015–April 2016 (n = 36)
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The selected strains were aligned using BioEdit. Bayesian information criterion was used to determine the model of nucleotide substitution that best fit the data 
using the selection tool available in MEGA6. The model that best fit the data was the Kimura 2-parameter model.
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tailored strategies should be directed at Roma com-
munities and HCW. It has been suggested that greater 
vaccination uptake may be achieved among Roma chil-
dren by inviting complete households for vaccination 
and by involving cultural mediators [11]. Also, control 
measures must be strengthened, including rapid case 
identification with implementation of airborne precau-
tions in healthcare facilities to avoid nosocomial trans-
mission [12].
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